Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology

Antonella Muraro, Graham Roberts, Margitta Worm, +27

Allergy

AsthmaClinical ImmunologyAllergy MedicineAllergenDrug Allergy +14

The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool

Choong‐Chin Liew, Jun Ma, Hong-Chang Tang, +2

Journal of Laboratory and Clinical Medicine

EngineeringGeneticsMultiomicsTranscriptomics TechnologySpatial Omics +14

Influence of particle morphology and size distribution on the powder flowability and laser powder bed fusion manufacturability of Ti-6Al-4V alloy

Salah Eddine Brika, Morgan Letenneur, Christopher Alex Dion, +1

Additive manufacturing

Clinical implications and utility of field cancerization

Gabriel D. Dakubo, John P. Jakupciak, Mark A. Birch‐Machin, +1

Cancer Cell International

A human immunodeficiency caused by mutations in the PIK3R1 gene

Marie‐Céline Deau, Lucie Heurtier, Pierre Frange, +8

Journal of Clinical Investigation

GeneticsApoptosisImmunologyImmune RegulationPathology +24

Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial

Anas Younes, Yasuhiro Oki, R. Gregory Bociek, +15

The Lancet Oncology

Relapsed Classical HodgkinLymphoid NeoplasiaOncologyPathologyCancer Treatment +3

Novel Aminophenyl Benzamide-Type Histone Deacetylase Inhibitors with Enhanced Potency and Selectivity

Oscar Moradei, Tammy C. Mallais, Sylvie Fréchette, +14

Journal of Medicinal Chemistry

Inhibitory ActivityMedicinal ChemistryBioorganic ChemistryBiochemistryUnusual Bis +13

The properties and microstructure of Al-based composites reinforced with ceramic particles

M.E. Smagorinski, P. Tsantrizos, S. Grenier, +3

Materials Science and Engineering A

Materials ScienceAl-based CompositesReinforcement MaterialMetal Matrix CompositeComposites +8

Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study

Eric Winquist, Jennifer J. Knox, Jean-Pierre M. Ayoub, +6

Investigational New Drugs

UrologyGenitourinary CancerMedicineMetastatic Renal CarcinomaAntisense Oligonucleotide Mg98 +5

A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors

Elisabeth I. Heath, Keith C. Bible, Robert E. Martell, +2

Investigational New Drugs

Cyclin-dependent Kinases 2OncologyMedicineWeekly InfusionAnti-cancer Agent +4